Identical hemodynamic and hormonal responses to 14-day infusions of renin or angiotensin II in conscious rats

Journal of Hypertension

Volumn 16, Issue 9, 1998, Pages 1285-1298

  Hu, Lufei ^a   Catanzaro, Daniel F ^a   Pitarresi, Tina Marie ^a   Laragh, John H ^a   Sealey, Jean E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Angiotensin II; Angiotensinogen; Blood pressure; Heart rate; Prorenin; Rat; Renin; Renin binding

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; POTASSIUM ION; PRORENIN; RENIN; SODIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DIURESIS; DRINKING; FLUID INTAKE; GLOMERULUS FILTRATION RATE; HEART RATE; HEMODYNAMICS; HORMONE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM URINE LEVEL;

EID: 0031655450     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816090-00010     Document Type: Article

References (44)

1. Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In: Laragh JH, Brenner BM (editors). Hypertension: pathophysiology, diagnosis and management. New York: Raven Press; 1995. pp. 1889-1895.
2. Rosenthal J, Swales JD, Dzau VJ. Vascular renin and hypertension. J Hypertens 1987; 5 (suppl II):S1-S78.
3. Swales JD. Arterial wall of plasma renin in hypertension? Clin Sci 1979; 56:293-298.
4. Mitchell KD, Navar LG. Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension. In: Laragh JH, Brenner BM (editors). Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press; 1995. pp. 1437-1450.
5. Levens NR, Peach MJ, Carey RM. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res 1981; 48:157-167.
6. Lutterotti NV, Catanzaro DF, Sealey JE, Laragh JH. Renin is not synthesized by cardiac and extrarenal vascular tissues: a review of experimental evidence. Circulation 1994; 89:458-470.
7. Skeggs LTJ, Dorer FE. Incorporation of labeled renin into the tissues of the rabbit. Am J Hypertens 1989; 2:768-779.
8. Loudon M, Bing RF, Thurston H, Swales JD. Arterial wall uptake of renal renin and blood pressure control. Hypertension 1983; 5:629-634.
9. Gould AB, Skeggs LT, Kahn JR. The presence of renin activity in blood vessel walls. J Exp Med 1964; 119:389-399.
10. de Lannoy LM, Danser AHJ, van Kats JP, Schoemaker RG, Saxena PR, Schalekamp MADH. Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I. Hypertension 1997; 29:1240-1251.
11. Sealey JE, Catanzaro DF, Lavin TN, Gahnem F, Pitarresi T, Hu L, et al. Specific prorenin/renin binding (ProBP): identification and characterization of a novel membrane site. Am J Hypertens 1996; 9:491-502.
12. Campbell DJ, Valentijn AJ. Identification of vascular renin-binding proteins by chemical cross-linking: inhibition of binding of renin by renin inhibitors. J Hypertens 1994; 12:879-890.
13. Hu L, Manning RD Jr, Brands MW. Long-term cardiovascular role of nitric oxide in conscious rats. Hypertension 1995; 23:185-194.
14. Dorer FE, Levine M, Skeggs LTJ, Lentz KE, Kahn JR. Purification of hog kidney renin using immobilized monoclonal antirenin. Hypertension 1984; 6:374-382.
15. Kim S, Hosoi M, Kikuchi N, Yamamoto K. Amino-terminal amino acid sequence and heterogeneity in glycosylation of rat renal renin. J Biol Chem 1991; 266:7044-7050.
16. Campbell WG Jr, Gahnem F, Catanzaro DF, James GD, Camargo MJF, Laragh JH, et al. Plasma and renin prorenin/renin, renin mRNA and blood pressure in Dahl S and R rats. Hypertension 1996; 27:1121-1133.
17. Bragat AC, Blumenfeld JD, Sealey JE. Effect of high-performance liquid chromatography on plasma angiotensin II measurements in treated and untreated normotensive and hypertensive patients. J Hypertens 1997; 15:459-465.
18. Smith HW. Principles of renal physiology. New York: Oxford University Press; 1960. pp. 196-214.
19. Dunnett CW. New tables for multiple comparisons with a control. Biometrics 1964; 20:482-491.
20. Baker HJ, Lindsey Russell J, Weisbroth SH: The laboratory rat (appendix 1: Selected normative data). New York: Academic Press; 1979. pp. 411-412.
21. Admiraal PJJ, Jan Danser AH, Sjoukje Jong M, Pieterman H, Derkx FHM, Schalekamp MADH. Regional angiotensin II production in essential hypertension and renal artery stenosis. Hypertension 1993; 21:173-184.
22. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 199; 18:763-773.
23. Navar LG, Von Thun AM, Zou LX, el-Dahr SS, Mitchell KD. Enhancement of intrarenal angiotensin II levels in 2 kidney 1 clip and angiotensin II induced hypertension. Blood Press 1995; 4 (suppl II):88-92.
24. Mistey M, Nasjletti A. Prostanoids as mediators of prohypertensive and antihypertensive mechanisms. Am J Med Sci 1988; 31:263-267
25. Fordis CM, Megorden JS, Ropchak RG, Keiser HR. Absence of renin-like activity in rat aorta and microvessels. Hypertension 1983, 5:635-641.
26. Cantin M, Gutkowska J, Lacasse J, Ballak M, Ledoux S, Inagami T, et al. Ultrastructural immunocytochemical localization of renin and angiotensin II in the juxtaglomerular cells of the ischemic kidney in experimental renal hypertension. Am J Pathol 1984; 115:212-224.
27. Inagami T, Kawamura M, Naruse K, Okamura T, Localization of components of the renin-angiotensin system within the kidney. Fed Proc 1986; 45:1414-1419.
28. Sealey JE, Evidence for cardiovascular effects of prorenin. J Hum Hypertens 1995; 9:381-384.
29. Dickinson CJ, Yu R. Mechanisms involved in the progressive pressor response to very small amounts of angiotensin in conscious rabbits. Circ Res 1967; 20,21 (suppl II):II157-II163.
30. Gahnem F, Camargo MJF, von Lutterotti N, Laragh JH, Sealey JE. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II. J Hypertens 1995; 13:91-96.
31. Blair-West JR, Reid IA, Ganong WF. Regulation of renin-substrate. In: Sambhi MP (editor). Excerpta Medica International Congress Series. Amsterdam: Elsevier Science Publishers BV; 1993. pp. 38-45.
32. Khayyall M, Brown JJ, Lever AF, Robertson JIS. Increase of plasma renin-substrate concentration after infusion of angiotensin in the rat. Clin Sci 1973; 44:87-90.
33. Nasjletti A, Masson GMC. Stimulation of angiotensinogen formation by renin and angiotensin. Proc Soc Exp Biol Med 1973; 142:307-310.
34. Nakamura A, Iwao H, Fukui K, Kimura S, Tamaki T, Nakanishi S, et al. Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II. Am J Physiol 1990; 258:E1-E6.
35. Simon G Abraham G. Angiotensin II administration as an experimental model of hypertension. In: Laragh JH, Brenner BM (editors). Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press; 1995; pp. 1423-1435.
36. Reid IA. Interactions between Ang II, sympathetic nervous system, and barorecepter reflexes in regulation of blood pressure. Am J Physiol 1993; 262:E763-E778.
37. Hall JE. Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol 1986; 250:R960-R972.
38. Brown AJ, Casals-Stenzel J, Gofford S, Lever AF, Morton JJ. Comparison of fast and slow pressor effects of angiotensin II in tne conscious rat. Am J Physiol 1981; 241:H381-H388.
39. Li Q, Dale WE, Hasser EM, Blaine EH. Acute and chronic angiotensin hypertension: neural and non neural components, time cause, and dose dependency. Am J Physiol 1996; 271:R200-R207.
40. Cowley AW, DeClue JW. Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotensin-induced hypertension in dogs. Circ Res 1976; 39:779-787.
41. Thaisrivongs S, Pals DT, Lawson JA, Turner SR, Harris DW. Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion blocked, hog renin infused rat model. J Med Chem 1987; 30:536-541.
42. Laragh JH. Renin system understanding for analysis and treatment of hypertensive patients; a means to quantify the vasoconstrictor elements, diagnose curable renal and adrenal causes, assess risk of cardiovascular morbidity, and find the best fit drug regimen. In: Laragh JH, Brenner BM (editors). Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press; 1995. pp. 1813-1836.
43. Cox BF, Bishop VS. Neural and humoral mechanisms of angiotensin-dependent hypertension. Am J Physiol 1991; 261;H1284-H1291.
44. Morganti A, Grassi G, Giannattasio C, Bolla G, Turolo L, Saino A, et al. Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension. J Hypertens 1989; 7:825-835.